9.36MMarket Cap-102P/E (TTM)
1.2000High1.0800Low573.87KVolume1.1500Open1.1400Pre Close658.74KTurnover6.75%Turnover RatioLossP/E (Static)8.51MShares14.400052wk High5.61P/B9.35MFloat Cap0.280652wk Low--Dividend TTM8.50MShs Float778.0000Historical High--Div YieldTTM10.53%Amplitude0.2800Historical Low1.1470Avg Price1Lot Size
Genprex Stock Forum
Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer
Genprex (NASDAQ: GNPX) has secured a worldwide exclusive license from the University of Michigan for patent rights relating to Reqorsa® Gene Therapy in combination with ALK-inhibitors for treating ALK-EML4 positive lung cancer. Preclinical data showed that Reqorsa induced apoptosis in alectinib resistant EML4-ALK positive non-small ...
Genprex Secures Global Patent Rights for Breakthrough Lung Cancer Gene Therapy | GNPX Stock News
today is the day
$Tesla (TSLA.US)$
$Artificial Intelligence (LIST2136.US)$
$NVIDIA (NVDA.US)$
$AT&T (T.US)$
$Phunware (PHUN.US)$
$Tesla (TSLA.US)$
fly to galaxia
$Apple (AAPL.US)$
fly to moon .....
$Tesla (TSLA.US)$
$NVIDIA (NVDA.US)$
No comment yet